Evidence map›Paper›PMID 34424383›Full record

ArticleAmino acids2022

Role of saturated and unsaturated fatty acids on dicarbonyl-albumin derived advanced glycation end products in vitro.

Brock Peake, Maulik Ghetia, Cobus Gerber, Maurizio Costabile, Permal Deo

Abstract read
PubMed Publisher
In one paragraph

Article in Amino acids, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Brock PeakeHealth and Biomedical Innovation, Clinical and Health Sciences, University of South Australia, Frome Road, Adelaide, SA, 5000, Australia. brock.peake@unisa.edu.au.ORCID http://orcid.org/0000-0002-7736-7922
Maulik GhetiaHealth and Biomedical Innovation, Clinical and Health Sciences, University of South Australia, Frome Road, Adelaide, SA, 5000, Australia.ORCID http://orcid.org/0000-0001-6340-9354
Cobus GerberHealth and Biomedical Innovation, Clinical and Health Sciences, University of South Australia, Frome Road, Adelaide, SA, 5000, Australia.ORCID http://orcid.org/0000-0001-9070-843X
Maurizio CostabileHealth and Biomedical Innovation, Clinical and Health Sciences, University of South Australia, Frome Road, Adelaide, SA, 5000, Australia.ORCID http://orcid.org/0000-0002-2162-6497
Permal DeoHealth and Biomedical Innovation, Clinical and Health Sciences, University of South Australia, Frome Road, Adelaide, SA, 5000, Australia. permal.deo@unisa.edu.au.ORCID http://orcid.org/0000-0002-6477-9127
University of South Australia · AUSouth Australia Pathology · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycation is a non-enzymatic reaction that occurs between the free amino group of proteins and reducing sugars and/or lipids, leading to the formation of advanced glycation end products (AGEs). The reaction also produces reactive oxygen species that have detrimental effects on cellular and extracellular proteins. Aminoguanidine is a known inhibitor of AGEs, and some fatty acids are known to have a beneficial role in vivo by reducing inflammation and oxidative stress. However, the role of fatty acids on AGE formation has not been thoroughly reported. We investigated the role of a range of fatty acids in the formation of AGEs and their reactive intermediates using an in vitro BSA-dicarbonyl model. The model assessed a time-dependent (0-72 h) and dicarbonyl concentration (0-2 mM) -dependent studies for the optimal formation of AGEs. A 72 h time point was found to be optimal for the reaction of BSA with either methylglyoxal (MGO) or glyoxal (GO) to generate AGE-BSA complexes. When arachidonic, eicosapentaenoic or docosahexaenoic acids were included in the reaction, a significant decrease in protein-bound fluorescent AGEs was seen compared to the respective controls. In contrast, saturated and 18 carbon polyunsaturated fatty acids showed no significant activity. Liquid chromatography-mass spectrometry (LC-MS/MS) analysis showed saturated fatty acids significantly decreased the production of N

Indexed as

Glycation End Products, AdvancedPyruvaldehydeChromatography, LiquidDocosahexaenoic AcidsFatty Acids, UnsaturatedGlyoxalMagnesium OxideTandem Mass SpectrometryDocosahexaenoic AcidsFatty Acids, UnsaturatedGlycation End Products, AdvancedGlyoxalMagnesium OxidePyruvaldehydeAdvanced glycation end productsBovine serum albuminFatty acidsGlyoxalKineticsMethylglyoxal

Identifiers

PMID34424383
OpenAlexW3195291679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.